DJ Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ slid 1.46% to $8.12 Friday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index rising 0.96% to 26,333.04 and the Dow Jones Industrial Average rising 0.98% to 52,573.29.
This was the stock's sixth consecutive day of losses.
Corbus Pharmaceuticals Holdings Inc. closed 60.51% short of its 52-week high of $20.56, which the company reached on October 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Vanda Pharmaceuticals Inc. $(VNDA)$ rose 0.99% to $5.09, Fortress Biotech Inc. (FBIO) fell 1.95% to $2.52, and Viking Therapeutics Inc. (VKTX) fell 0.47% to $31.98.
Trading volume (1.5 M) eclipsed its 50-day average volume of 436,037.
Data source: Dow Jones Market Data, FactSet. Data compiled September 11, 2026.